«Xcyte Therapies Incorporated

Below is an extended Xcyte Therapies Incorporated research listing. Click here to return to the Xcyte Therapies Incorporated main Biocorporate entry.

Recent Publications by Xcyte Therapies Incorporated:
Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversity. Assessment of the diversity of the T-cell receptor (TCR) repertoire is...	14th February, 2007	Xcyte	J Immunol Methods. 2006 Dec 20;317(1-2):100-13. Epub 2006 Oct 17. DOI Direct Link
GMP production and testing of Xcellerated T Cells for the treatment of patients with CLL. BACKGROUND: Pre-clinical studies suggest Xcellerated T Cells have the...	17th September, 2005	Xcyte Therapies Inc. Seattle Washington 98104, USA.	Cytotherapy. 2004;6(6):554-62. DOI Direct Link
In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia. Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of...	30th March, 2005	Xcyte Therapies, Inc., Seattle, WA 98104, USA.	J Immunol. 2005 Feb 15;174(4):2366-75.
Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies. T-cell receptor engagement and accompanying costimulatory signals control...	3rd February, 2005	Xcyte Therapies, Inc., Seattle, Washington 98104, USA.	J Immunother. 2004 Sep-Oct;27(5):405-18.
Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complex. The TCR-CD3 complex consists of the clonotypic disulfide-linked...	9th October, 2002	Xcyte Therapies, Inc., Seattle, WA 98104, USA.	Int Immunol. 2002 Apr;14(4):389-400.
IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells. The cellular and humoral immune system is critically dependent upon...	8th May, 2000	Xcyte Therapies,	J Immunol. 2000 Apr 1;164(7):3500-5.

«Xcyte Therapies Incorporated

This page contained an extended Xcyte Therapies Incorporated research listing. Click here to return to the Xcyte Therapies Incorporated main Biocorporate entry.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.